Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Qishenyiqi Dripping Pills in Patients With Ventricular Remodeling and Chronic Heart Failure With Reduced Ejection Fraction After Myocardial Infarction

NCT06699407 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT06699407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06699407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Qishenyiqi Dripping Pills in Patients With Ventricular Remodeling and Chronic Heart Failure With Reduced Ejection Fraction After Myocardial Infarction
Lead sponsor
Qilu Hospital of Shandong University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 20, 2024
Completion date
December 31, 2027
Enrollment
210 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic stable heart failure